AIM
PEAR

Acropolis Investment Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Acropolis Investment Management’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-164,842
Closed -$336K – 254
2022
Q3 		$336K Buy
+164,842
New +$336K 0.03% 151